Therma Bright Inc. (TSXV:THRM)
0.0550
0.00 (0.00%)
Jun 1, 2026, 11:26 AM EST
Therma Bright Revenue
Therma Bright had revenue of 19.32K CAD in the quarter ending January 31, 2026, a decrease of -28.71%. This brings the company's revenue in the last twelve months to 67.45K, up 134.11% year-over-year. In the fiscal year ending July 31, 2025, Therma Bright had annual revenue of 75.23K with 1,150.67% growth.
Revenue (ttm)
67.45K
Revenue Growth
+134.11%
P/S Ratio
49.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | 75.23K | 69.21K | 1,150.67% |
| Jul 31, 2024 | 6.02K | 3.96K | 192.56% |
| Jul 31, 2023 | 2.06K | -137.37K | -98.53% |
| Jul 31, 2022 | 139.43K | 135.54K | 3,490.70% |
| Jul 31, 2021 | 3.88K | 100.00 | 2.64% |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evome Medical Technologies | 48.34M |
| Aurora Spine | 25.67M |
| Conavi Medical | 778.00K |
| Frequency Exchange | 745.08K |
| MedX Health | 473.27K |
| NuGen Medical Devices | 257.95K |
| Ventripoint Diagnostics | 179.93K |
| VVT Med | 156.00K |
Therma Bright News
- 27 days ago - Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets - Newsfile Corp
- 2 months ago - Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually - Newsfile Corp
- 2 months ago - Therma Bright Grants Stock Options - Newsfile Corp
- 3 months ago - Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial - Newsfile Corp
- 4 months ago - Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med - Newsfile Corp
- 8 months ago - Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors - Newsfile Corp
- 8 months ago - Therma Bright Expands Relationship with Distribution Partner Gen-X Med for Venowave(TM) Sales - Newsfile Corp
- 9 months ago - Therma Bright Proposes to Amend Certain Warrants - Newsfile Corp